Sarah Kathryn Rouan Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah Kathryn Rouan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah Kathryn Rouan. Sarah Kathryn Rouan is a Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a Director in Viking Therapeutics, Inc. ($VKTX).
Address: 4995 BRADENTON AVE., SUITE 240 DUBLIN 43017 OH
Companies in which Sarah Kathryn Rouan is an Insider
NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Sarah Kathryn Rouan: Director
Holdings: 13,350 shares
Current Value: $6,942
Latest Transaction: Jan 14 2021
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viking Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Kathryn Rouan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 06 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sarah Kathryn Rouan
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 2.28 | 2,500 | 5,700 | 2,500 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Rouan Sarah Kathryn | Director | Grant | A | 0.00 | 2,500 | 3 | 13,350 | 10.9 K to 13.4 K (+23.04 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 5.80 | 22,000 | 127,600 | 22,000 | |
| Feb 07 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 1.06 | 2,500 | 2,650 | 7,500 | |
| Feb 07 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Rouan Sarah Kathryn | Director | Grant | A | 0.00 | 2,500 | 3 | 10,850 | 8.4 K to 10.9 K (+29.94 %) |
| Jan 03 2020 | VKTX | Viking Therapeutic ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 7.95 | 22,000 | 174,900 | 22,000 | |
| Jul 02 2019 | VKTX | Viking Therapeutic ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 8.32 | 55,000 | 457,600 | 55,000 |